WellnessFX

Short answer: several routine and a few advanced blood biomarkers are consistently linked to long-term mortality and healthy lifespan. The most useful ones are those that track metabolic health, atherosclerotic risk, inflammation, kidney/liver function, oxygen-carrying capacity, and key micronutrient deficiencies. Focus first on modifiable, well‑validated tests (glucose control, ApoB/LDL, inflammation, kidney function, A1c), then add advanced tests (LDL‑particle number, Lp(a), NMR/GlycA, cystatin C) if you want deeper risk stratification. Below is a practical, prioritized list with why each matters, typical “good” targets (approximate — individual targets vary), and how to improve results. Top priorities Hemoglobin A1c (HbA1c) and fasting glucose / fasting insulin Why: Chronic hyperglycemia and insulin resistance predict diabetes, cardiovascular disease, dementia, and higher mortality. Rough target: HbA1c in the non‑diabetic range (generally <5.7%); many healthy people target ~5.0–5.6%. Fasting glucose <100 mg/dL. Lower fasting insulin / HOMA‑IR indicates better insulin sensitivity. How to improve: weight loss, improved diet (lower refined carbs), resistance + aerobic exercise, sleep, and medications when appropriate (metformin, GLP‑1 agonists). Lipids with particle measures: ApoB, LDL‑particle number (LDL‑P), LDL‑C, non‑HDL, triglycerides, HDL Why: Atherosclerotic cardiovascular disease (the leading cause of death) is best tracked by particle burden (ApoB/LDL‑P) rather than LDL‑C alone. Rough target: ApoB <80 mg/dL (lower if high risk), LDL‑P and non‑HDL as low as your risk profile warrants (many high‑risk patients aim LDL <70 mg/dL). Triglycerides <150 mg/dL; HDL higher is usually better. How to improve: diet quality, weight loss, statins/ezetimibe/PCSK9 inhibitors as indicated, exercise, reduce refined carbs and alcohol. Important and actionable High‑sensitivity CRP (hs‑CRP) and other inflammation markers (IL‑6, GlycA) Why: Chronic low‑grade inflammation (“inflammaging”) predicts mortality, cardiovascular events, and disability. Rough target: hs‑CRP <1 mg/L is low risk; 1–3 mg/L moderate; >3 mg/L higher risk. How to improve: weight loss, exercise, smoking cessation, statins, dietary improvements; specific anti‑inflammatory drugs are used in selected cases but are not routine. Lipoprotein(a) — Lp(a) Why: Strong genetic driver of atherosclerotic and valvular disease; one‑time test is usually enough because levels are largely inherited. Rough target: ideally <30–50 nmol/L (or <30–50 mg/dL depending on units); elevated levels merit specialist input. How to improve: limited; some PCSK9 inhibitors modestly lower Lp(a); new therapies (antisense oligonucleotides) are in development. Kidney function: serum creatinine/eGFR, cystatin C, urine albumin‑to‑creatinine ratio (UACR) Why: Reduced kidney function and albuminuria strongly predict cardiovascular disease and death. Rough target: eGFR >60 mL/min/1.73m2; UACR <30 mg/g. How to improve: blood pressure control (ACEi/ARB), glycemic control, avoid nephrotoxins, treat underlying causes. Complete blood count components — hemoglobin, hematocrit, RDW (red cell distribution width), WBC Why: Low hemoglobin (anemia) and high RDW/WBC count associate with higher mortality and frailty. How to improve: identify causes (iron/B12 deficiency, chronic disease), treat appropriately. Liver enzymes and markers of fatty liver (ALT, AST, GGT, fasting triglycerides) Why: NAFLD and elevated GGT/ALT associate with metabolic disease and worse long‑term outcomes. How to improve: weight loss, exercise, treat metabolic syndrome. Useful micronutrients / endocrine markers 25‑hydroxy vitamin D Why: Very low levels associate with poor health; supplementation corrects deficiency. Typical target: 30–50 ng/mL for most adults (individualize). Vitamin B12/folate, ferritin (if indicated) Why: Deficiencies cause anemia, neuropathy, and poor functional outcomes. Thyroid tests (TSH, free T4; free T3 if symptomatic) Why: Untreated hypo/hyperthyroidism affects metabolism, cognition, and cardiovascular risk. Advanced/specialty markers (for deeper risk stratification) ApoB and LDL‑P (NMR or apoB lab) Why: Better predictors of atherosclerotic risk than LDL‑C alone. How to get it: NMR Lipoprofile (LabCorp), ApoB via Quest or LabCorp, or advanced lipid panels from specialty labs. GlycA (NMR inflammation signal), IL‑6, TNF‑alpha Why: Emerging, strong predictors of long‑term risk and frailty. Cystatin C (refined eGFR) and urine biomarkers for earlier kidney disease detection. How often to test Healthy adults: basic panels (CBC, CMP, fasting lipids, HbA1c) annually. If abnormalities or higher risk: every 3–6 months while optimizing or on therapy. One‑time tests: Lp(a) (once unless family history or therapy change), ApoB/LDL‑P if you want a better baseline. Practical next steps (what I’d recommend) Start with: fasting metabolic panel + lipid panel + HbA1c + hs‑CRP + CBC + kidney/liver tests + vitamin D. Add ApoB or NMR/LDL‑P if you want precise CV risk. If you have personal/family CVD or early CVD: add Lp(a) and consider referral to a lipid specialist. Where to get these tests (brands/services) LabCorp and Quest Diagnostics — widely available, full panels and specialty tests (ApoB, Lp(a), NMR LipoProfile via LabCorp). InsideTracker or WellnessFX — consumer‑facing platforms that combine lab testing with personalized interpretation and lifestyle recommendations. Nightingale Health — advanced NMR metabolomics (more common in Europe) for GlycA and detailed metabolite profiling. Everlywell or LetsGetChecked — convenient home sample kits for common tests (A1c, lipids, vitamin D, etc.) if you prefer at‑home draws. Local primary care or a preventive cardiology/lipid clinic — for interpretation and prescription decisions (statins, BP meds, advanced therapies). Cautions Associations ≠ causation: some markers predict risk but lowering them does not always change outcomes (interpret with clinician). Targets must be individualized by age, sex, comorbidities, and medications; very low values in older adults can sometimes be harmful. Don’t chase single numbers — focus on overall risk reduction: blood pressure control, smoking cessation, body composition, cardiorespiratory fitness, good sleep, diet, and control of diabetes/lipids. If you want, tell me your age, sex, major medical history, and any recent lab results and I’ll prioritize which tests to get and give more specific target ranges and action steps.

Mentioned in position 4 of 7

Short answer: Yes — for many routine blood and at‑home tests you can order them yourself without a doctor. Whether it’s “worth it” depends on what you want to accomplish, how you’ll act on the results, and which provider you use. What’s available In‑person blood draws ordered by a consumer (you get a lab requisition and go to a draw site): LabCorp Pixel, QuestDirect, HealthLabs.com, Walk‑In Lab, PrivateMDLabs. These use CLIA‑certified labs and offer broad test menus (CBC, lipids, metabolic panel, TSH, HbA1c, vitamin D, hormones, etc.). At‑home kits (fingerstick, saliva, or swab): Everlywell, LetsGetChecked, imaware, MyLabBox (STIs). Good for convenience and privacy; many partner with CLIA labs and include nurse/physician review for abnormal results. Specialty/performance/genetic: InsideTracker and WellnessFX for performance/nutrition; 23andMe for consumer genetic reports (some health reports FDA‑cleared). For clinical genetic testing (actionable medical genes), Invitae and Color Genomics are reputable and offer counseling. Why pick the reputable names above LabCorp Pixel / QuestDirect: big national lab networks, wide test menus, CLIA‑certified, reliable assays and easy draw site access. HealthLabs / Walk‑In Lab / PrivateMDLabs: competitive pricing and allow you to get a physician requisition so you can use standard draw sites; good for common screening panels. Everlywell / LetsGetChecked: convenient at‑home sampling, clear instructions, and clinical support if results are abnormal. InsideTracker: targeted toward athletic/performance metrics with actionable lifestyle recommendations. 23andMe / Invitae / Color: clear differentiation between consumer vs clinical genetic testing; Invitae and Color are designed for medical follow‑up and counseling. Limitations and risks Not all tests are appropriate without clinical context. Broad “check everything” panels often create false positives or incidental findings that cause anxiety and unnecessary follow‑ups. Some tests (certain hormone panels, autoimmune tests, genetic tests) require careful interpretation and repeat/confirmatory testing in a medical setting. Insurance: many DTC tests are paid out‑of‑pocket and not reimbursed unless ordered by your clinician. Some companies provide paperwork so you can submit to insurance — check beforehand. Privacy: read the company’s privacy policy. Genetic and health data may be used in de‑identified research or shared under some terms. Legal/regulatory: reputable providers use CLIA‑certified labs; FDA oversight varies by test. When it’s most worth it Monitoring a known condition (thyroid, lipids, HbA1c) when you want convenience. Getting an initial screening (lipids, basic metabolic panel, CBC, TSH) if you don’t have a primary care visit coming up. Privacy‑sensitive STI or hormone checks where you prefer at‑home sampling. Tracking targeted biomarkers for training or nutrition with a plan for how you’ll use the data. When you should see a doctor instead New or worsening symptoms, acute illness, or complex multisystem problems. If a test result would change medication or requires medical management (start/stop meds) — involve a clinician. For interpretation of complex labs or genetic results and arranging confirmatory/diagnostic testing. Practical tips Decide the specific question you want answered (e.g., “Do I have high cholesterol?” vs “run every test”). Targeted testing is cheaper and more actionable. Choose a CLIA‑certified lab or a vendor that partners with one. Prefer services that include clinician review or easy ways to share results with your primary care provider. If you get an abnormal result, confirm with a clinician before making major health decisions. If you tell me what you want to check (cholesterol/heart risk, thyroid, anemia, hormones, STIs, genetic risk, athlete performance, etc.), I can recommend 1–2 specific services and which exact tests to order.

Mentioned in position 11 of 14

Short answer: it depends a lot on which biomarkers you mean. Typical ranges (US, approximations as of 2024): Basic clinical panels (lipid panel, CMP, CBC, HbA1c): $10–$200 if paid out‑of‑pocket. Many physician-ordered tests at LabCorp or Quest Diagnostics are often covered by insurance (copay or deductible may apply). Expanded “wellness” panels (lipids + metabolic + thyroid + vitamin D + inflammation + hormones): $100–$600 for direct‑to‑consumer or clinic bundles. Advanced or specialty biomarkers (advanced lipoprotein testing, micronutrient panels, cytokines, hormone panels, tumor markers): $200–$2,000 depending on how many markers and lab complexity. Genomic and multi‑omics tests (23andMe/genotyping, whole-genome sequencing, proteomics, deep microbiome or metabolomics): $99 (basic consumer genotyping) to several hundred for WGS, and $500–3,000+ for clinical-grade multi‑omics and specialized assays. Multi‑cancer early detection tests (e.g., Galleri): roughly $700–1,000+. Examples of providers and why you might pick them Quest Diagnostics / LabCorp: broad test menu, thousands of draw sites, physician-ordered (often insurance-covered). Everlywell / LetsGetChecked: convenient at‑home collection kits for common panels (lipids, hormones, vitamins); typically $49–$249 and easy to order without a clinic visit. InsideTracker / WellnessFX: wellness-focused blood panels plus personalized interpretation and recommendations; good if you want lifestyle recommendations tied to results. 23andMe / Ancestry: consumer genetic (SNP) reports ~ $99 for ancestry + some health reports. Nebula Genomics / Dante Labs (or clinical WGS providers): whole‑genome sequencing options if you want full genomic data (prices vary widely by coverage). Viome / DayTwo: microbiome/metatranscriptome testing for gut health; prices vary by service and subscription. Other practical notes Insurance often covers medically necessary tests ordered by a clinician; direct‑to‑consumer kits usually are out‑of‑pocket. Collection method affects price: fingerstick at‑home kits are cheaper; venous draws at a lab or clinic may be required for some tests. Turnaround times vary from 1–2 days (basic panels) to several weeks (specialized assays or sequencing). If you tell me which specific biomarkers or goals you have (e.g., cardiovascular risk, hormone health, micronutrients, cancer screening, genetics), I can give a more precise price estimate and recommend specific kits/labs.

Mentioned in position 6 of 13

Short answer: It depends on the biomarker, your health status, medications, and whether a result was abnormal. Below is a practical schedule you can use and the common reasons to test more or less often. Typical retest intervals (healthy adult, stable results) Basic metabolic panel (electrolytes, kidney/liver function): annually. Sooner if you start new medications that affect kidneys/liver or have chronic disease. Complete blood count (CBC): annually. Repeat sooner for unexplained anemia, bleeding, or infection. Lipid panel (total cholesterol, LDL, HDL, triglycerides): every 4–6 years for low-risk adults; annually if you have cardiovascular risk factors or are on/change statins. Hemoglobin A1c (diabetes screening/monitoring): every 3 years if normal and low-risk; every 3 months if you have diabetes and are changing therapy or not at goal; every 6 months if diabetes is stable. Fasting glucose (or random glucose): annually for most adults; earlier if overweight/other risk factors. Thyroid-stimulating hormone (TSH): every 6–12 months if you are on thyroid therapy or have abnormal TSH; every 1–2 years if previously normal and asymptomatic. Vitamin D (25‑OH D): only test if deficiency suspected or you’re treating deficiency; recheck ~8–12 weeks after starting supplements, then every 6–12 months if ongoing therapy. Ferritin/iron studies: repeat 2–3 months after treatment for deficiency or sooner if symptoms persist. High-sensitivity CRP and other inflammatory markers: only as clinically indicated, not routine. PSA (prostate-specific antigen): frequency varies by age/risk and shared decision-making—commonly every 1–2 years in men who choose screening. Special tests (hormones, autoimmune markers, tumor markers): follow your specialist’s schedule. When to test more frequently Starting or changing medications (statins, thyroid meds, diabetes drugs, anticoagulants). New or worsening symptoms. Known chronic conditions (diabetes, chronic kidney disease, heart disease). Recent abnormal result — follow-up testing until stable. When less frequent testing is reasonable Young, healthy people with repeatedly normal results and low risk factors. Where to get tests (options and why) Local primary care or health system labs (Labcorp, Quest Diagnostics): comprehensive panels, widely accepted by clinicians and insurance. Direct-to-consumer at-home kits (Everlywell, LetsGetChecked): convenient for screening and monitoring simple markers; good if you need convenience but confirm abnormal results with a clinical lab/doctor. Personalized biomarker services (InsideTracker, WellnessFX): offer trend tracking and lifestyle recommendations — useful if you want data-driven coaching, but expect added cost. Continuous monitoring (if relevant): Dexcom or FreeStyle Libre for people who need ongoing glucose tracking (diabetes or metabolic optimization). Telehealth/primary-care platforms (One Medical, Forward, your insurance’s telehealth): helpful for interpretation and follow-up. Final notes These are general recommendations. Individual frequency should be tailored to your age, family history, medications, and medical conditions. Talk with your clinician to set a testing schedule. If you want, tell me your age, major medical conditions, medications, and any recent abnormal labs and I can suggest a more specific retesting plan.

Mentioned in position 6 of 10

Short answer: there’s no single “longevity” blood test, but a set of reliably predictive biomarkers track the biggest drivers of lifespan and healthy aging — cardiovascular disease, metabolic disease, inflammation, organ function, and nutritional deficits. Below I list the most important blood biomarkers, why they matter, what to watch for, how often to test, and a few specific labs/services that can run them or give extra interpretation. Top biomarkers to watch (what they say and why) Lipids and atherogenic markers LDL‑C, non‑HDL‑C, triglycerides, HDL‑C — core CVD risk markers. High LDL/non‑HDL and triglycerides → higher atherosclerotic risk. ApoB and LDL particle number (LDL‑P or NMR lipoprofile) — better predictors of atherosclerosis than LDL‑C alone. Lp(a) — genetically determined independent risk factor for early atherosclerosis; test once in adulthood. Why: cardiovascular disease is the leading cause of death; these markers predict risk and guide treatment. Glucose metabolism Fasting glucose, HbA1c, fasting insulin, (or OGTT if indicated), HOMA‑IR. Why: dysglycemia and insulin resistance drive diabetes, cardiovascular disease, dementia — major longevity determinants. Inflammation and immune activation hs‑CRP (high‑sensitivity C‑reactive protein), IL‑6 (if available), fibrinogen, neutrophil:lymphocyte ratio. Why: chronic low‑grade inflammation (“inflammaging”) predicts multimorbidity and mortality. Kidney function Serum creatinine/eGFR, cystatin C, urine albumin:creatinine ratio (ACR). Why: CKD raises mortality and accelerates other aging pathways. Cardiac injury/stress markers NT‑proBNP (heart stress), high‑sensitivity troponin. Why: detect subclinical heart disease/risk even when other tests look OK. Liver function & metabolic health ALT, AST, GGT, albumin, bilirubin. Why: fatty liver and liver dysfunction are linked to metabolic disease and mortality. Complete blood count (CBC) & related Hemoglobin, hematocrit, white cell count, platelets, RDW (red cell distribution width). Why: anemia, elevated RDW, and abnormal WBC patterns associate with frailty and higher mortality. Micronutrients & related 25‑OH vitamin D, vitamin B12, folate, iron studies/ferritin. Why: deficiencies cause frailty, cognitive problems, and increased disease risk — many are fixable. Hormones relevant to aging Total and free testosterone (in men if indicated), estradiol (women as appropriate), SHBG, DHEA‑S, TSH/free T4 (thyroid). Why: hormone deficiencies or imbalances affect muscle, bone, metabolism, cognition and frailty. Growth factors and other aging markers (interpret with nuance) IGF‑1 — associated with growth/cancer/aging pathways (U‑shaped relationships). Homocysteine — elevated levels linked to CVD and cognitive decline. Omega‑3 index — low index linked to higher cardiac risk. Why: these are informative but typically need contextual interpretation. Emerging/biological‑age tests (optional) DNA methylation clocks (epigenetic age; e.g., GrimAge) and telomere length assays. Why: give an estimate of biological age and response to interventions — still evolving, useful for tracking but not diagnostic. What to test and how often Core annual panel for most adults: fasting lipid panel (or advanced lipoprotein testing if family history), fasting glucose and/or HbA1c, hs‑CRP, CMP (kidney/liver/electrolytes), CBC, TSH, vitamin D, B12, ferritin. Add apoB/LDL‑P and Lp(a) if personal/family history of premature CVD — Lp(a) can be tested once. NT‑proBNP/hs‑troponin if heart disease risk or symptoms. Repeat frequency: annually for stable people; every 3–6 months if you’re treating an abnormality or making major lifestyle/medication changes. Specific labs/services (why you might use them) LabCorp or Quest Diagnostics — broad coverage, clinical‑grade testing, widely used by clinicians; good for standard panels, Lp(a), apoB, NT‑proBNP, IL‑6 (available). InsideTracker — consumer‑facing panel + personalized interpretation and lifestyle recommendations geared toward performance/longevity; useful if you want actionable coaching with lab data. WellnessFX (or Vault by Wellness) — similar consumer service with clinician review and lifestyle guidance. Everlywell, LetsGetChecked — convenient at‑home collection kits for common panels (glucose, lipids, hormones); good for screening but limited for some specialized markers. OmegaQuant — specialty lab for the omega‑3 index (most clinical labs don’t run this). TruDiagnostic (or Chronomics) — DNA methylation clocks/epigenetic age testing if you want biological age tracking. TeloYears (if still available) or SpectraCell — telomere length assays (useful but more experimental/monitoring). Cleveland HeartLab and specialized CVD labs — for advanced inflammatory and atherothrombotic biomarkers if your clinician is managing complex CVD risk. Interpreting results and next steps Targets vary by age, sex, and risk. For example, LDL goals are lower for people with known CVD or diabetes. Many biomarkers have U‑shaped relationships with outcomes (very low or very high can both be bad), so context matters. Abnormal tests should prompt discussion with a clinician before starting supplements/medications. Lifestyle modifications (exercise, Mediterranean/whole‑food diet, smoking cessation, sleep, stress reduction, weight control) move many of these markers in the right direction. Caveats Some tests (epigenetic clocks, telomere length) are still emerging and should be used for tracking trends, not diagnostic certainty. Don’t over‑test without a plan — focus on biomarkers that change management. Always review abnormal results with a qualified clinician. If you’d like, tell me: your age, sex, major medical history, and what you can test easily (lab access), and I’ll propose a specific baseline panel and testing frequency — and which services to use for each test.

Mentioned in position 4 of 13

Short answer: several blood biomarkers strongly track risk of age‑related disease and all‑cause mortality. The most useful ones for “longevity” are those that reflect cardiometabolic risk, inflammation, organ function, nutrition, and biological aging. Below I list the high‑priority markers, why they matter, reasonable target directions, how to change them, testing cadence, and a few lab/consumer services you can use. High‑priority blood biomarkers for longevity (what they mean and practical targets) Glycemic control HbA1c: reflects average glucose. Why: higher HbA1c predicts diabetes, cardiovascular disease, and mortality. Target: ideally <5.7% (non‑diabetic range); keep as low as safely possible without hypoglycemia. Interventions: weight loss, Mediterranean/low‑refined‑carb eating patterns, exercise, sleep, and, if indicated, medications under a clinician’s guidance. Fasting glucose / fasting insulin: fasting glucose <100 mg/dL; fasting insulin lower is generally better (fasting insulin <10 µIU/mL often used), because insulin resistance is a key aging driver. Atherogenic lipids & lipoproteins ApoB (preferred) and LDL‑C, non‑HDL, triglycerides: Why: atherogenic particle number (ApoB) is strongly linked to cardiovascular mortality. Targets vary by risk—general longevity goal: ApoB <80 mg/dL (lower if high risk), LDL‑C often <100 mg/dL (or <70 mg/dL if high risk). TG <150 mg/dL. Lp(a): genetically driven atherosclerotic risk; lower is better. Consider testing once (Lp(a) is mostly fixed by genetics). Thresholds: >50 mg/dL (≈125 nmol/L) indicates elevated risk. Inflammation High‑sensitivity CRP (hs‑CRP): chronic inflammation predicts CVD and mortality. Target: <1 mg/L is low risk; >3 mg/L is high. Interventions: weight loss, exercise, smoking cessation, Mediterranean diet, treat infections/periodontal disease, consider statin therapy if indicated. IL‑6 and other cytokines are informative in research/complex cases but not routine for most people. Kidney function Serum creatinine with eGFR and cystatin C (if available): kidney function decline is a strong mortality predictor. Target: eGFR >60 mL/min/1.73m2; rising creatinine or cystatin C signals risk. Liver health ALT, AST, GGT: elevated enzymes (especially GGT) are associated with metabolic dysfunction and mortality. Keep within normal range; investigate persistent elevations. Hematology & general reserves Hemoglobin/hematocrit and albumin: anemia and low albumin are independently associated with worse outcomes in older adults. Keep hemoglobin in normal range for sex/age; albumin >3.5–4.0 g/dL. Nutritional markers 25‑hydroxy vitamin D: low levels associate with worse outcomes. Target commonly 30–50 ng/mL (many clinicians aim ~30–50 or 40–60 for older adults). Vitamin B12, folate, ferritin (iron stores): correct deficiencies (B12 especially in older adults). Omega‑3 index (erythrocyte EPA+DHA): higher omega‑3 index correlates with lower cardiac mortality; measured by specialty labs—target often ≥8%. Coagulation / clotting risk D‑dimer and fibrinogen sometimes predict risk in older adults; used in context. Hormones & growth factors (age/context dependent) Testosterone/estradiol (when clinically indicated): low testosterone in men is associated with frailty; but hormone replacement is nuanced. IGF‑1: linked to aging biology; extremes (very high or very low) can increase risk. Interpretation is complex—no universal target; consider in research/clinical contexts. Markers of biological age / epigenetic clocks (optional, emerging) DNA methylation clocks (Horvath/GrimAge), telomere length, GlycanAge: these are evolving but can give an integrated measure of biological age. Use for tracking interventions rather than clinical decision‑making. Practical testing frequency Healthy adult with no specific risks: annual basic panel (CMP, lipid panel, CBC, HbA1c, hs‑CRP, vitamin D/B12) is reasonable. If you have risk factors (family history, high BP, dyslipidemia, prediabetes), test more often (every 3–6 months while addressing abnormalities). Some tests are one‑time (Lp[a], genetic risk) unless changes are expected. How to use these results Focus on modifiable drivers: smoking cessation, BP control, weight loss if overweight, physical activity (resistance + aerobic), Mediterranean/whole‑food diet, sleep, stress reduction, vaccination, and evidence‑based medications when clinically indicated (statins, antihypertensives, diabetes meds). Treat abnormalities in context—e.g., a mildly elevated CRP with obesity should prompt weight/fat loss and evaluation for infection/inflammatory conditions. Caveats Associations vs causation: many biomarkers are risk correlates, not direct “aging clocks.” Interventions that change the biomarker are most valuable when they also reduce hard outcomes (heart attacks, strokes, disability). Targets vary by age, sex, comorbidities, and personal risk tolerance—discuss abnormal results with your clinician. Over‑testing and overtreatment can be harmful; prioritize actionable markers. Recommended labs / services (short list and why) Quest Diagnostics and Labcorp — nationwide clinical labs that perform comprehensive panels (lipids, HbA1c, CMP, hs‑CRP, ApoB, Lp(a), cystatin C). Good for physician‑ordered tests and many DTC requisitions. OmegaQuant — specialized lab for the omega‑3 index (erythrocyte EPA+DHA), useful if you want a reliable omega‑3 biomarker. InsideTracker and WellnessFX — consumer services that combine lab testing with easily actionable recommendations and coaching. Good if you want interpretation and lifestyle guidance tailored to results. Everlywell and LetsGetChecked — at‑home testing kits for common markers (lipids, HbA1c, vitamin D, etc.). Convenient for screening but limited for complex testing. TruDiagnostic (or similar providers) — for DNA methylation (epigenetic) age testing. Useful if you want to track biological age as an experimental measure. If you want, I can: Suggest a compact “longevity panel” you can order right now based on your age/sex/health history. Explain how to interpret any specific lab result you have (send values and reference ranges).

Mentioned in position 5 of 8